title: Association of coronary heart disease with pre-beta-HDL concentrations in Japanese men.
abstract: BACKGROUND
  In individuals heterozygous for ABCA1 transporter mutations, defective reverse cholesterol transport (RCT) causes low HDL-cholesterol and premature coronary heart disease (CHD). However, the extent to which impaired RCT underlies premature CHD in others with low HDL-cholesterol is not known. The primary acceptors of cell cholesterol are a minor subclass of lipid-poor pre-beta-HDLs. These are generated during remodeling of alpha-HDLs, which account for almost all HDL-cholesterol. We studied the strength of the association of CHD with pre-beta-HDL concentrations in Japanese men.
  
  
  METHODS
  Blood was collected from 42 men with clinical CHD and 44 healthy controls 40-70 years of age. Pre-beta-HDL was assayed by crossed immunoelectrophoresis.
  
  
  RESULTS
  Cases had lower HDL-cholesterol (-23%), total apolipoprotein A-I (-26%), and pre-beta-HDL (-55%; all P <0.001) concentrations; lower pre-beta-HDL:alpha-HDL ratios (-45%; P <0.001); and higher plasma triglycerides (20%; P <0.03) than the controls. On stepwise logistic regression, CHD was associated most strongly with pre-beta-HDL concentrations. On ROC analysis, pre-beta-HDL concentration discriminated between cases and controls better than any other lipoprotein measurement. When plasma was incubated for 16 h at 37 degrees C, mean (SD) pre-beta-HDL increased by 47 (36)% in controls, but was unchanged in cases (group difference, P <0.001).
  
  
  CONCLUSIONS
  Our results suggest that inefficient RCT, secondary to a low pre-beta-HDL concentration and production rate in plasma, contributes to premature CHD in Japanese men with low HDL-cholesterol.
authors.affiliation: Department of Advanced Medical Technology and Development, BML, Kawagoe, Saitama, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Hattori
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kujiraoka
authors.forename: Tohru
authors.initials: T
authors.lastname: Egashira
authors.forename: Eiji
authors.initials: E
authors.lastname: Saito
authors.forename: Takayuki
authors.initials: T
authors.lastname: Fujioka
authors.forename: Sadao
authors.initials: S
authors.lastname: Takahashi
authors.forename: Mayumi
authors.initials: M
authors.lastname: Ito
authors.forename: Jackie A
authors.initials: JA
authors.lastname: Cooper
authors.forename: Irina P
authors.initials: IP
authors.lastname: Stepanova
authors.forename: M Nazeem
authors.initials: MN
authors.lastname: Nanjee
authors.forename: Norman E
authors.initials: NE
authors.lastname: Miller
mesh_terms: D000328:Adult; D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000175:diagnosis; D053442:High-Density Lipoproteins, Pre-beta; D006801:Humans; D007564:Japan; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D016632:Apolipoprotein A-I; D053442:High-Density Lipoproteins, Pre-beta; D008075:Lipoproteins, HDL